Latin America Digital Dose Inhaler Market Size & Outlook

The digital dose inhaler market in Latin America is expected to reach a projected revenue of US$ 1,583.5 million by 2030. A compound annual growth rate of 17.3% is expected of Latin America digital dose inhaler market from 2024 to 2030.
Revenue, 2023 (US$M)
$517.0
Forecast, 2030 (US$M)
$1,583.5
CAGR, 2024 - 2030
17.3%
Report Coverage
Latin America

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Latin America digital dose inhaler market, 2018-2030 (US$M)

Latin America digital dose inhaler market, 2018-2030 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Latin America digital dose inhaler market highlights

  • The Latin America digital dose inhaler market generated a revenue of USD 517.0 million in 2023.
  • The market is expected to grow at a CAGR of 17.3% from 2024 to 2030.
  • In terms of segment, dry powdered inhalers (dpis) was the largest revenue generating product in 2023.
  • Dry Powdered Inhalers (DPIs) is the most lucrative product segment registering the fastest growth during the forecast period.


Latin America data book summary

Market revenue in 2023USD 517.0 million
Market revenue in 2030USD 1,583.5 million
Growth rate17.3% (CAGR from 2023 to 2030)
Largest segmentDry powdered inhalers (dpis)
Fastest growing segmentDry Powdered Inhalers (DPIs)
Historical data covered2018 - 2022
Base year for estimation2023
Forecast period covered2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationDry Powdered Inhalers (DPIs)
Key market players worldwide3M Co, AstraZeneca PLC, Novartis AG ADR, ResMed Inc, OPKO Health Inc, Teva Pharmaceutical Industries Ltd, Beximco Pharmaceuticals Ltd DR, GlaxoSmithKline, Glenmark Pharmaceuticals, Sensirion, Mundipharma


Other key industry trends

  • In terms of revenue, Latin America region accounted for 3.4% of the global digital dose inhaler market in 2023.
  • Globally, North America is projected to lead the regional market in terms of revenue in 2030.
  • Asia Pacific is the fastest growing regional market and is projected to reach USD 10,434.2 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Digital Dose Inhaler Market Companies

Name Profile # Employees HQ Website
Mundipharma View profile 1001-5000 Cambridge, Cambridgeshire, United Kingdom, Europe http://www.mundipharma.com
Glenmark Pharmaceuticals View profile 10001+ Andheri, Maharashtra, India, Asia http://www.glenmarkpharma.com
Sensirion View profile 1001-5000 Stafa, Zurich, Switzerland, Europe http://www.sensirion.com
GlaxoSmithKline View profile 10001+ London, England, United Kingdom, Europe http://www.gsk.com
Beximco Pharmaceuticals Ltd DR View profile 5700 19 Dhanmondi, Road No. 7, Dhaka, Bangladesh, 1205 https://www.beximcopharma.com
OPKO Health Inc View profile 3930 4400 Biscayne Boulevard, Miami, FL, United States, 33137 https://www.opko.com
AstraZeneca PLC View profile 89900 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge, United Kingdom, CB2 0AA https://www.astrazeneca.com
3M Co View profile 85000 3M Center, St. Paul, MN, United States, 55144 https://www.3m.com
ResMed Inc View profile 10140 9001 Spectrum Center Boulevard, San Diego, CA, United States, 92123 https://www.resmed.com
Teva Pharmaceutical Industries Ltd View profile 37851 124 Dvora HaNevi’a Street, Tel Aviv, Israel, 6944020 https://www.tevapharm.com
Novartis AG ADR View profile 76057 Lichtstrasse 35, Basel, Switzerland, 4056 https://www.novartis.com

Latin America digital dose inhaler market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to digital dose inhaler market will help companies and investors design strategic landscapes.


Dry powdered inhalers (dpis) was the largest segment with a revenue share of 100% in 2023. Horizon Databook has segmented the Latin America digital dose inhaler market based on dry powdered inhalers (dpis) covering the revenue growth of each sub-segment from 2018 to 2030.


Reasons to subscribe to Latin America digital dose inhaler market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Latin America digital dose inhaler market databook

  • Our clientele includes a mix of digital dose inhaler market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of continent-level data and insights on the Latin America digital dose inhaler market , including forecasts for subscribers. This continent databook contains high-level insights into Latin America digital dose inhaler market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more
Chat with us
Research Assistance
Online